IP Library Granted Patent US 10,241,047
Granted Patent B2
US 10,241,047 · App. 15/716,616 · Granted Mar 26, 2019

Method for analysing a sample comprising at least a first and a second scale inhibitor

Inventors: Vesa Nuutinen (Helsinki, FI); Susanna Toivonen (Espoo, FI); James Johnstone (Banchory, GB); Harri Härmä (Turku, FI); Mirva Lehmusto (Turku, FI); Satu Tiittanen (Turku, FI); Pave Väisänen (Helsinki, FI); Joonas Siivonen (Turku, FI); Paul Mundill (Espoo, FI)
Assignee: Kemira Oyj
G01N21/6408G01N1/34G01N1/38G01N21/77G01N2021/6419G01N2021/6421G01N2021/7786
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,241,047
App. No.
15/716,616
Granted
Mar 26, 2019
Kind
B2
Abstract

The invention relates to a method for analysing a sample comprising at least a first and a second scale inhibitor, which scale inhibitors are synthetic organic compounds comprising at least one ionised group. The method comprises optionally diluting and/or purifying the sample, and allowing the sample interact with a reagent comprising lanthanide(III) ion. The sample is excited at a first excitation wavelength and a sample signal deriving from the lanthanide(III) ion is detected at a signal wavelength by using time-resolved luminescence measurement. The total concentration of the first and the second scale inhibitor is determined by using the detected sample signal, and the concentration of the first scale inhibitor in the sample is determined. The concentration of the second scale inhibitor is determined mathematically by using the obtained results for the total concentration and for the first scale inhibitor concentration.

Claims (35)

1. Method for analysing a sample comprising at least a first and a second scale inhibitor, which scale inhibitors are synthetic organic compounds comprising at least one ionised group, and determining concentrations of the scale inhibitors in an industrial water system,

the method comprising

optionally diluting and/or purifying the sample,

allowing the sample interact with a reagent comprising lanthanide(III) ion,

exciting the sample at a first excitation wavelength and detecting a sample signal deriving from the lanthanide(III) ion at a signal wavelength by using time-resolved luminescence measurement,

determining the total concentration of the first and the second scale inhibitor by using the detected sample signal,

determining the concentration of the first scale inhibitor in the sample,

determining the concentration of the second scale inhibitor mathematically by using the obtained results for the total concentration and for the first scale inhibitor concentration.

2. Method according to claim 1 , wherein the concentration of the first scale inhibitor is determined by exciting the sample at a second excitation wavelength and detecting a first scale inhibitor signal by using time-resolved luminescence measurement.

3. Method according to claim 2 , wherein the first scale inhibitor signal is detected at the signal wavelength or a first signal wavelength, which is different from the signal wavelength wherein the difference between the first excitation wavelength and second excitation wavelength, and any successive excitation wavelength, is preferably at least 10 nm, more preferably at least 20 nm, even more preferably at least 25 nm.

4. Method according to claim 1 , wherein the time-resolved luminescence measurement is time-resolved fluorescence measurement.

5. Method according to claim 1 , wherein the concentration of the first, second and/or any successive scale inhibitor is determined by using luminescence, direct fluorescence, absorbance, spectrophotometry, optical rotation measurement, photon counting, inductively coupled plasma (IPC), high-performance liquid chromatography (HPLC), liquid chromatography-mass spectrometry (LC-MS), size exclusion chromatography, colorimetric methods, NMR, time-resolved luminescence, or a combination thereof.

6. Method according to claim 1 , wherein the reagent comprising lanthanide(III) ion is a lanthanide(III) salt or a luminescent lanthanide chelate.

7. Method according to claim 1 wherein the lanthanide(III) ion is selected from reagents comprising europium, terbium, samarium or dysprosium ions, preferably from europium or terbium ions.

8. Method according to claim 1 , wherein the concentration of the lanthanide(III) ion is in the range of 0.01-10 mM, preferably 0.01-1 mM, more preferably 0.01 mM -0.1 mM, even more preferably about 0.01 mM.

9. Method according to claim 1 , wherein the first and/or second scale inhibitors comprise two or more ionised groups, which are selected from phosphates, phosphonates, carboxylates, sulphonates, and/or amines, preferably from carboxylates, sulphonates and/or amines.

10. Method according to claim 9 , wherein the scale inhibitors are selected from group comprising polyelectrolyte compounds comprising carboxylate and/or phosphonate groups; homopolymers and copolymers of ethylenically unsaturated acid monomers; organophosphonates, and combinations thereof.

11. Method according to claim 1 , wherein the industrial water system is selected from a group consisting of

cooling tower water systems;

boilers and boiler water systems;

mineral process waters;

paper mill digesters, washers, bleach plants and white water systems;

black liquor evaporators in the pulp industry;

gas scrubbers and air washers;

continuous casting processes in the metallurgical industry;

air conditioning and refrigeration systems;

indirect contact cooling and heating water;

water reclamation and purification systems;

membrane filtration water systems;

food processing streams; and

waste treatment systems.

12. Method according to claim 1 , wherein the method is performed as on-line measurement.

13. Method according to claim 1 , wherein the scale inhibitor is anionic.

14. Method according to claim 1 , wherein the first and/or second scale inhibitor is a polycarboxylic acid selected from polyacrylic acid, polymethacrylic acid, polymaleic acid or any of their salts with monovalent cations.

15. Method according to claim 1 , wherein the scale inhibitor has a molecular weight of from 500 to 100 000 Daltons, more preferably 500-30 000 Daltons, even more preferably 500-12 000 Daltons.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 27, 2024
From: KEMIRA OYJ
To: STERLING SPECIALTY CHEMICALS HOLDING UK LIMITED
Reel/Frame 066699/0200 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2018
From: NUUTINEN, VESA; JOHNSTONE, JAMES; TOIVONEN, SUSANNA
To: KEMIRA OYJ
Reel/Frame 047619/0796 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2018
From: HÄRMÄ, HARRI; LEHMUSTO, MIRVA; TIITTANEN, SATU; VÄISÄNEN, PAVE; SIIVONEN, JOONAS; MUNDILL, PAUL
To: AQSENS OY
Reel/Frame 047620/0914 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 29, 2018
From: AQSENS OY
To: KEMIRA OYJ
Reel/Frame 047621/0076 →
Priority Claims (1)
FI 20136152 · Nov 19, 2013 · national
Continuity (2)
Continuation 15037682
Related Publication 20180017494A1 · Jan 18, 2018